Mutant p53 gain of function: Differential effects of different p53 mutants on resistance of cultured cells to chemotherapy

Oncogene

Volumn 18, Issue 2, 1999, Pages 477-485

  Blandino, Giovanni ^a   Levine, Arnold J ^b   Oren, Moshe ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b PRINCETON UNIVERSITY   (United States)

Author keywords

Apoptosis; Chemoresistance; Etoposide; Mutant p53

Indexed keywords

ETOPOSIDE; HISTIDINE; MUTANT PROTEIN; PROTEIN P53; TRYPTOPHAN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; PROGNOSIS; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL SEPARATION; CELL SURVIVAL; CISPLATIN; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENES, P53; HUMANS; LUNG NEOPLASMS; MUTATION;

EID: 0033552948     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202314     Document Type: Article

References (48)

1. Aas T, Borresen AL, Geisler S, Smith-Sorensen B, Johnsen H, Varhaug JE, Akslen LA and Lonning PE. (1996). Nature Med., 2, 811-814.
2. Bergh J, Norberg T, Sjogren S, Lindgren A and Holmberg L. (1995). Nature Med., 1, 1029-1034.
3. Borresen AL, Andersen TI, Eyfjord JE, Cornelis RS, Thorlacius S, Borg A, Johansson U, Theillet C, Scherneck S, Hartman S et al. (1995). Genes Chromosom. Cancer, 14, 71-75.
4. Chin KV, Ueda K, Pastan I and Gottesman MM. (1992). Science, 255, 459-462.
5. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Wyllie A. (1993). Nature, 362, 849-852.
6. Cote RJDE, Groshen S, Jones PA and Skinner DG. (1997). Nature, 385, 123-124.
7. Darzynkiewicz Z. (1995). J. Cell. Biochem., 58, 151-159.
8. Deb S, Jackson CT, Subler MA and Martin DW. (1992). J. Virol., 66, 6164-6170.
9. Dittmer D, Pati S, Zambetti G, Chu S, Tereseky K, Moore M, Finlay C and Levine AJ. (1993). Nature Genet., 4, 42-46.
10. El Rouby S, Thomas A, Costin D, Rosenberg C, Potmesil M, Silber R and Newcomb EW. (1993). Blood, 82, 3452-3459.
11. Fisher DE. (1994). Cell, 78, 539-542.
12. Fraizer MW, He X, Wang J, Gu Z, Cleveland JL and Zambetti GP. (1998). Mol. Cell. Biol., 18, 3735-3743.
13. Fritsche M, Haessler C and Brandner G. (1993). Oncogene, 8, 307-318.
14. Goh H-S, Yao J and Wurl P. (1995). Cancer Res., 55, 5217-5221.
15. Gualberto A, Aldape K, Kozakiewicz K and Tlsty TD. (1998). Proc. Natl. Acad. Sci. USA, 95, 5166-5171.
16. Hamada M, Fujiwara T, Hizuta A, Gochi A, Naomoto Y, Takakura N, Takahashi K, Roth JA, Tanaka N and Orita K. (1996). J. Cancer Res. Clin. Oncol., 122, 360-365.
17. Hansen R and Oren M. (1997). Curr. Op. Genet. Dev., 7, 46-51.
18. Haupt Y, Rowan S, Shaulian E, Vousden KH and Oren M. (1995). Genes Dev., 9, 2170-2183.
19. Hinds PW, Finlay CA, Quartin RS, Baker SJ, Fearon ER, Vogelstein B and Levine AJ. (1990). Cell Growth Diff., 1, 571-580.
20. Hollstein M, Soussi T, Thomas G, von-Brevern M and Bartsch H. (1997). Recent Results Cancer Res., 143, 369-389.
21. Hsiao M, Low J, Dorn E, Ku D, Pattengale P, Yeargin J and Haas M. (1994). Am. J. Pathol., 145, 702-714.
22. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW. (1991). Cancer Res., 51, 6304-6311.
23. Kremenetskaya OS, Logacheva NP, Baryshnikov AY, Chumakov PM and Kopnin BP. (1997). Oncol. Res., 9, 155-166.
24. Lanyi A, Deb D, Seymour RC, Ludes-Meyers JH, Subler MA and Deb S. (1998). Oncogene, 16, 3169-3176.
25. Levine AJ. (1997). Cell, 88, 323-331.
26. Li R, Sutphin DP, Schwartz D, Matas D, Almog N, Wolkowicz R, Goldfinger N, Pei H, Prokocimer M and Rotter V. (1998). Oncogene, 16, 3269-3278.
27. Lotem J and Sachs L. (1995). Proc. Natl. Acad. Sci. USA, 92, 9672-9676.
28. Lowe SW. (1995). Curr. Opin. Oncol., 7, 547-553.
29. Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T. (1993). Nature, 362, 847-849.
30. Ludes-Meyers JH, Subler MA, Shivakumar CV, Munoz RM, Jiang P, Bigger JE, Brown DR, Deb SP and Deb S. (1996). Mol. Cell. Biol., 16, 6009-6019.
31. Makris A, Powles TJ, Dowsett M and Allred C. (1995). Lancet, 345, 1181-1182.
32. Mathieu C, Koscielny S, Le Bihan ML, Spielmann M and Arriagada R. (1995). Lancet, 345, 1182.
33. Michalovitz D, Halevy O and Oren M. (1991). J. Cell. Biochem., 45, 22-29.
34. Milner J. (1995). Trends Biochem. Sci., 20, 49-51.
35. Mitsudomi T, Steinberg SM, Nau MM, Carbone D, D'Amico D, Bodner S, Oie HK, Linnoila RI, Mulshine JL, Minna JD et al. (1995). Oncogene, 7, 171-180.
36. Peled A, Zipori D and Rotter V. (1996). Cancer Res., 56, 2148-2156.
37. Reeve JG, Xiong J, Morgan J and Bleehen NM. (1996). Br. J. Cancer, 73, 1193-1200.
38. Ribiero JC, Barneston AR, Fisher RJ, Mameghan H and Russel PJ. (1997). Int. J. Radiat. Biol., 72, 11-20.
39. Righelti SC, Della Torre G, Pilotti S, Menard S, Ottone F, Colnaghi MI, Pierotti MA, Lavarino C, Cornarotti M, Oriana S et al. (1996). Cancer Res., 56, 689-693.
40. Rusch V, Klimstra D, Venkatraman E, Oliver J, Martini N, Gralla R, Kris M and Dmitrovsky E. (1995). Cancer Res., 55, 5038-5042.
41. Sakamuro D, Sabbatini P, White E and Prendergast GC. (1997). Oncogene, 15, 887-898.
42. Traubert H, Meye A and Wurl P. (1996). Cancer Res., 56, 4134-4136.
43. Tsutsumi-Ishi Y, Tadokoro A, Hanaoka F and Tsuchida N. (1995). Cell. Growth. Diff., 6, 1-8.
44. Walker KK and Levine AJ. (1996). Proc. Natl. Acad. Sci. USA, 93, 15335-15340.
45. Wang XW, Yeh H, Schaefler L, Roy R, Moncollin V, Egly JM, Wang Z et al. (1996). Genes Dev., 10, 1219-1232.
46. Wattel E, Preudhomme C, Hecquet B, Vanrumbeke M, Quesnel B, Dervite I, Morel P and Fenaux P. (1994). Blood, 84, 3148-3157.
47. Wolf D, Harris N and Rotter V. (1984). Cell, 38, 119-126.
48. Zhan QM, Carrier F and Fornace AJ. (1993). Mol. Cell. Biol., 13, 4242-4250.